氧化型血小板脂质组的调控:与冠状动脉疾病的相关性
本研究探讨有症状的冠状动脉疾病(CAD)患者血小板脂质组变化,以及趋化因子CXCL12及其受体CXCR-4/-7对血小板脂质摄取的功能影响。结果显示CAD患者血小板-氧化低密度脂蛋白(oxLDL)结合增强(P=0.04),并与CXCR7表面表达呈中度正相关(ρ=0.39;P<0.001),与CXCR4呈负相关(ρ=0.35;P<0.001);LDL-oxLDL可诱导血小板氧化应激、脱颗粒、整合素αIIbβ3活化、凋亡、凝血酶生成及血栓形成,且CXCL12可协同增强上述效应。结论认为血小板脂质组改变可能与CAD血栓倾向相关,其机制可能受CXCL12-CXCR4-CXCR7轴调控。
要点
- CAD患者血小板-oxLDL结合增强(P=0.04),与CXCR7表达正相关(ρ=0.39),与CXCR4负相关(ρ=0.35)。
- ACS伴冠脉内血栓者血小板-oxLDL升高(P=0.01),血栓切片血小板富集区可见oxLDL沉积。
- LDL-oxLDL诱导血小板氧化应激、活化、凋亡及血栓形成,CXCL12协同增强该效应。
核心结论
- 血小板脂质组改变可能与CAD血栓倾向相关,其机制可能受CXCL12-CXCR4-CXCR7轴调控。
研究设计与样本
- 研究纳入有症状的CAD患者,检测血小板-oxLDL、血小板脂质组,并分析CXCL12及其受体对血小板脂质摄取的功能影响;同时进行体外实验和小鼠在体血栓形成实验。
主要发现
- CAD患者血小板-oxLDL较对照增强(P=0.04),与血小板CXCR7表面表达呈中度正相关(ρ=0.39;P<0.001),与CXCR4呈负相关(ρ=0.35;P<0.001)。
- ACS伴冠脉内血栓造影证据的患者血小板-oxLDL升高(P=0.01);冠脉内血栓切片免疫荧光共聚焦显示血小板富集区有oxLDL沉积。
- LDL-oxLDL摄取增强活性氧、线粒体超氧化物生成、血小板内LDL向oxLDL转化及脂质过氧化,SOD2模拟物MnTMPyP可拮抗上述效应。
- 脂质组学分析显示CAD患者较年龄匹配对照血小板内氧化磷脂、胆固醇酯、鞘磷脂、神经酰胺、二酰基甘油和三酰基甘油、酰基肉碱增强。
- LDL-oxLDL诱导血小板脱颗粒、αIIbβ3整合素活化、凋亡、凝血酶生成及形态改变,并增强体外和小鼠在体血栓形成;LDL-oxLDL增强血小板CXCL12释放,差异调节CXCR4-CXCR7表面暴露,CXCL12促进LDL-oxLDL摄取并协同增强其促氧化和促血栓效应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Hyperlipidaemia enhances susceptibility to thrombosis, while platelet oxidixed LDL (oxLDL) binding in acute coronary syndrome (ACS) correlates with activation status. This study explores the platelet lipidome in symptomatic coronary artery disease (CAD) patients and the functional consequences of the chemokine CXCL12 and its receptors CXCR-4/-7 on lipid uptake in platelets. METHODS AND RESULTS: Platelet-oxLDL detected by flow cytometry was enhanced (P = 0.04) in CAD patients, moderately correlated with platelet CXCR7 surface expression (ρ = 0.39; P < 0.001), while inversely with CXCR4 (ρ = 0.35; P < 0.001). Platelet-oxLDL was elevated (P = 0.01) in ACS patients with angiographic evidence of intracoronary thrombi. Ex vivo analysis of intracoronary thrombi sections revealed oxLDL deposition in platelet-enriched areas verified by immunofluorescence confocal microscopy. LDL-oxLDL uptake enhanced reactive oxygen species, mitochondrial superoxide generation, intraplatelet LDL to oxLDL conversion, and lipid peroxidation, counteracted by SOD2-mimetic MnTMPyP. Lipidomic analysis revealed enhanced intraplatelet-oxidized phospholipids, cholesteryl esters, sphingomyelin, ceramides, di- and triacylglycerols, acylcarnitines in CAD patients compared with age-matched controls as ascertained by liquid chromatography hyphenated to high-resolution mass spectrometry. LDL-oxLDL induced degranulation, αIIbβ3-integrin activation, apoptosis, thrombin generation estimated by calibrated automated thrombinoscopy, and shape change verified by live imaging using scanning ion conductance microscopy. Further, LDL-oxLDL enhanced thrombus formation ex vivo and in vivo in mice (ferric chloride-induced carotid artery injury). LDL-oxLDL enhanced platelet CXCL12 release, differentially regulated CXCR4-CXCR7 surface exposure, while CXCL12 prompted LDL-oxLDL uptake and synergistically augmented the LDL-oxLDL-induced pro-oxidative, thrombogenic impact on platelet function. CONCLUSION: An altered platelet lipidome might be associated with thrombotic disposition in CAD, a mechanism potentially regulated by CXCL12-CXCR4-CXCR7 axis.
引用
- Chatterjee M, Rath D, Schlotterbeck J, et al. Regulation of oxidized platelet lipidome: implications for coronary artery disease. Eur Heart J. 2017. PMID: 28431006. doi:10.1093/eurheartj/ehx146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。